Welcome to our dedicated page for Diamondrock Hospitality Co SEC filings (Ticker: DRH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Parsing DiamondRock Hospitality’s filings can feel like wading through 250 pages of hotel metrics—RevPAR swings, seasonal cash-flow curves, and renovation budgets buried deep in footnotes. If you have ever wondered, “How do I find DiamondRock Hospitality’s quarterly earnings report 10-Q filing or track executive stock transactions Form 4 in real time?” you are not alone.
Stock Titan solves this. Our AI-powered summaries turn dense documents into clear insights, showing exactly where the 10-K discusses room-rate sensitivities or where the 8-K flags a new resort acquisition. Need to monitor DiamondRock Hospitality insider trading Form 4 transactions? Alerts arrive the moment management files. Looking for the next dividend clue inside a DiamondRock Hospitality earnings report filing analysis? We highlight cash available for distribution, debt covenants, and cap-ex obligations—no spreadsheet gymnastics required.
Every DRH disclosure is here, updated the instant EDGAR posts it:
- DiamondRock Hospitality annual report 10-K simplified—understand segment RevPAR, property impairments, and balance-sheet leverage in minutes.
- DiamondRock Hospitality quarterly earnings report 10-Q filing—spot occupancy trends and seasonal revenue shifts.
- DiamondRock Hospitality proxy statement executive compensation—see how incentive fees align with guest-satisfaction scores.
- DiamondRock Hospitality 8-K material events explained—from hurricane closures to new franchise agreements.
- DiamondRock Hospitality Form 4 insider transactions real-time—track buying and selling patterns before the market reacts.
Stop piecing together spreadsheets and PDFs. With Stock Titan you’re understanding DiamondRock Hospitality SEC documents with AI, gaining clarity that informs investment decisions faster than ever.
On 22 Jul 2025 DiamondRock Hospitality (NYSE: DRH) executed a Seventh Amended & Restated Credit Agreement that upsizes its unsecured credit facility from $1.2 bn to $1.5 bn and extends maturities.
- $400 m revolving credit line maturing 21 Jan 2030; two optional 6-month extensions.
- Three term loans totalling $1.1 bn: $500 m due 3 Jan 2028, $300 m due 21 Jan 2029, $300 m due 21 Jan 2030; Term 1 & Term 3 may each be extended twice.
- Accordion feature can lift total commitments to $1.8 bn.
- Pricing unchanged at SOFR +1.35%–2.25%, driven by leverage tiers; unused revolver fee 0.20%–0.25%.
- Covenants remain: max leverage 60%, fixed-charge cover ≥1.5×, secured debt <45% of asset value.
The incremental $300 m fully covers repayment of three mortgage loans maturing in 2025 (≈$291.6 m). After the planned pre-payment of the $166.6 m Westin Boston Seaport loan in Sep-25, DRH will have no debt maturities until Jan-2028 and its hotel portfolio will be entirely unencumbered.
The refinancing bolsters liquidity, cuts near-term refinancing risk and preserves borrowing costs, though drawing the added capacity could lift leverage.
Ikena Oncology (IKNA) filed an 8-K announcing its board has declared a one-time special dividend of one contingent value right (CVR) for every outstanding share held as of the close of business on 24 Jul 2025. The CVRs are being issued in connection with the previously disclosed two-step merger with Inmagene Biopharmaceuticals.
Under the contemplated CVR Agreement, holders will receive (i) 100% of net proceeds, if any, from milestone, royalty or earn-out payments tied to dispositions of IKNA’s pre-merger assets and (ii) 90% of net proceeds from dispositions executed within one year after closing, both after permitted deductions (taxes, expenses, litigation and wind-down costs). If no such proceeds arise during the CVR term, the CVRs will expire worthless.
The merger structure remains unchanged: Merger Sub I merges into Inmagene, followed immediately by Inmagene into Merger Sub II, creating a wholly-owned subsidiary of IKNA. Forward-looking statements caution that closing conditions, expense control, legal proceedings and asset-sale milestones may affect both the merger and any CVR payout.